NCT02333851View on ClinicalTrials.gov

Basal-bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes (PININ Study)

PHASE4TerminatedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Mixtard 30:70 Novonordisk® twice daily

Premixed insulin twice daily before breakfast and before dinner

DRUG

Lantus® once daily and Apidra® before meals

Injection of Lantus® insulin once daily and rapid insulin Apidra® before breakfast, lunch and dinner

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Hospital Universitario Central de Asturias

OTHER

NCT02333851 - Basal-bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes (PININ Study) | Biotech Hunter | Biotech Hunter